Colorado board permits state to appeal injunction against arthritis drug price cap

Colorado board permits state to appeal injunction against arthritis drug price cap

A Colorado board voted Friday to allow the Attorney General’s Office to fight an injunction against a price cap on a drug that treats arthritis. A U.S. district court judge had granted the company Amgen a preliminary injunction, temporarily blocking Colorado from imposing a price cap on Enbrel, an injectable commonly used to treat arthritis. […]

Original Source

Read the full article at Coloradopolitics →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.